WeVote
Log In

Bill

Bill

SB 6051

Concerning manslaughter when certain controlled substances are sold that result in death of the user.

2023-2024 Regular Session Introduced by John Braun and 8 co-sponsors

Washington bill would charge drug sellers with manslaughter if their sold substances cause user deaths, expanding criminal liability for overdose fatalities.

First reading, referred to Law & Justice.
0
WeVote Research Nonpartisan
Bill Summary · SB 6051

Legislative bill overview

SB 6051 would create criminal liability for individuals who sell controlled substances that directly result in a user's death, treating such cases as manslaughter. The bill expands criminal responsibility beyond traditional drug dealing statutes by specifically targeting fatal overdose scenarios caused by substance sales.

Why is this important

Overdose deaths have become a leading cause of unintentional injury deaths in Washington and nationwide, with fentanyl and other potent substances driving fatality rates. This legislation attempts to deter high-risk drug sales and hold sellers accountable when their products cause deaths, though it fundamentally shifts legal responsibility in ways that require careful implementation.

Potential points of contention

  • Causation challenges: Establishing direct causation between a specific sale and a death is legally and evidentiary complex, especially when users may consume multiple substances or have underlying health conditions
  • Culpability debates: Opponents argue sellers may not know the potency or composition of substances they distribute, raising questions about intent and fairness of manslaughter charges versus other drug-related offenses
  • Precedent concerns: Similar laws in other states have faced constitutional challenges and variable enforcement, with some resulting in unintended consequences like reduced emergency reporting of overdoses

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.